"The matter is not closed until Toyota has effectively addressed the defect by providing a suitable vehicle-based solution," said the regulatory agency.
Boston Scientific says it identified the cause of the problem, a design flaw, and has already changed how it makes its stents to address the defect that leads to problems in some cases.
While Boston Scientific says it has identified the design flaw that was the cause of the problem, and changed how it makes the stents to address the defect, the company said yesterday that it had identified problems in its method of inspecting the stents at its plant in Galway, Ireland, during the first three days of a new inspection process.
In Section 2, we review the SVC and the related resource allocation algorithms, and then address the defects in the previous algorithms.
Treatments that delay or reduce cell loss will provide time to patients, while therapies that address the defects can be developed and applied to the remaining, non-degenerating cell populations.
Certainly, therapies directed at addressing the misfolding defect in the most common CFTR mutant, and other mutant forms, by targeting the associated chaperone system would simplify the clinical approach.
The 5-year VERIFY study will investigate if addressing the different pathophysiological defects in Type 2 diabetes mellitus by early initiation of vildagliptin metformin combination treatment will result in lower treatment failure rate or in lower HbA1c progression over time, compared with metformin monotherapy, followed by the addition of a second oral anti-diabetic agent (vildagliptin).
Those who think that Europe simply must address the founding defect of the euro now and move towards a European economic government must deal with these two awkward facts.
And, while this drug targets a very specific form of cystic fibrosis that occurs in only four per cent of patients, the fact that similar drugs — which are also intended to address the basic defect in the faulty CFTR protein and which have shown promising results in initial laboratory trials — are being developed by Vertex and other companies seems to signal a new treatment paradigm.
